Akt/eNOS signaling pathway mediates inhibition of endothelial progenitor cells by palmitate-induced ceramide

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 308, Issue 1, 2015, Pages H11-H17

  Fu, Minghuan ^a   Li, Zhihong ^b   Tan, Tao ^c   Guo, Weixin ^d   Xie, Nanzi ^e   Liu, Qing ^a   Zhu, Hua ^c   Xie, Xiaoyun ^e   Lei, Han ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

^c OHIO STATE UNIVERSITY   (United States)

^d GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Ceramide; Endothelial progenitor cells; Nitric oxide; Palmitate; Stem cells

Indexed keywords

CERAMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FUMONISIN B1; N OLEOYLETHANOLAMINE; NITROPRUSSIDE SODIUM; PALMITIC ACID; PROTEIN KINASE B; THERMOZYMOCIDIN; ENZYME INHIBITOR; NITRIC OXIDE; NITRIC OXIDE DONOR; NOS3 PROTEIN, HUMAN;

ARTICLE; CELL ADHESION ASSAY; CELL MIGRATION; DEACYLATION; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANGIOGENESIS; CELL ADHESION; CELL CULTURE; CELL MOTION; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; TIME;

CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CERAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOTHELIAL PROGENITOR CELLS; ENZYME INHIBITORS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; PALMITIC ACID; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84925230294     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00503.2014     Document Type: Article

References (30)

1. Asahara T, Kawamoto A, Masuda H. Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29: 1650- 1655, 2011.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastorc C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999.
3. Barthclmes D, Irhimeh MR, Gillies MC, Karimipour M, Zhou M, Zhu L, Shen WY. Diabetes impairs mobilization of mouse bone marrow- derived Lin-/VEGF-R2+ progenitor cells. Blood Cells Mol Dis 51: 163-173, 2013.
4. Batra S, Reynolds CP, Maurer BJ. Fenretinide cytotoxicity for Ewing’s sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. Cancer Res 64: 5415-5424, 2004.
5. Boden G, Salehi S. Why does obesity increase the risk for cardiovascular disease? Curr Pharm Des 19: 5678-5683, 2013.
6. Chakraborty M, Jiang XC. Sphingomyelin and its role in cellular signaling. Adv Exp Med Biol 991: 1-14, 2013.
7. Chavez JA, Summers SA. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419: 101-109, 2003.
8. Desouza CV. Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes? J Diabetes Complications 27: 519-525, 2013.
9. Dragoni S, Laforenza U, Bonetti E, Lodola F, Bottino C, Guerra G, Borghesi A, Stronati M, Rosti V, Tanzi F, Moccia F. Canonical transient receptor potential 3 channel triggers vascular endothelial growth factor-induced intracellular Ca2+ oscillations in endothelial progenitor cells isolated from umbilical cord blood. Stem Cells Dev 22: 2561-2580, 2013.
10. Everaert BR, Van Craenenbrocck EM, Hoymans VY, Haine SE, Van Nassauw L, Conraads VM, Timmermans JP, Vrints CJ. Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. Int J Cardiol 144: 350-366, 2010.
11. Galadari S, Rahman A, Pallichankandy S, Galadari A, Thayyullathil F. Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis 12: 98, 2013.
12. Geft D, Schwartzenberg S, George J. Circulating endothelial progenitor cells in cardiovascular disorders. Exp Rev Cardiovasc Ther 6: 1115-1121, 2008.
13. Guo WX, Yang QD, Liu YH, Xie XY, Wang M, Niu RC. Palmitic and linoleic acids impair endothelial progenitor cells by inhibition of Akt/eNOS pathway. Arch Med Res 39: 434-442, 2008.
14. Hage Hassan R, Bourron O, Hajduch E. Defect of insulin signal in peripheral tissues: Important role of ceramide. World J Diabetes 5: 244- 257, 2014.
15. Hibbert B, Sirnard T, Ramirez FD, Pourdjabbar A, Raizman JE, Maze R, Wilson KR, Hawken S, O’Brien ER. The effect of statins on circulating endothelial progenitor cells in humans: a systematic review. J Cardiovasc Pharmacol 62: 491-496, 2013.
16. Jin F, Fondell JD. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression. Nucleic Acids Res 37: 4826-4838, 2009.
17. Ma J, Both SK, Yang F, Cul FZ, Pan J, Meijer GJ, Jansen JA, van den Beucken JJ. Concise review: cell-based strategies in bone tissue engineering and regenerative medicine. Stem Cells Transl Med 3: 98-107, 2014.
18. Martelii AM, Tabellini G, Brcssanin D, Ognibene A, Goto K, Cocco L, Evangclisti C. The emerging multiple roles of nuclear Akt. Biochim Biophys Acta 1823: 2168-2178, 2012.
19. Mehra VC, Jackson E, Zhang XM, Jiang XC, Dobrucki LW, Yu J, Bernatchez P, Sinusas AJ, Shulnian GI, Sessa WC, Yarovinsky TO, Bender JR. Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis. Am J Pathol 184: 1562-1576, 2014.
20. Montefusco DJ, Chen L, Matmati N, Lu S, Newcomb B, Cooper GF, Hannun YA, Lu X. Distinct signaling roles of ceramide species in yeast revealed through systematic perturbation and systems biology analyses. Science Signaling 6: rsl4, 2013.
21. Prokopi M, Pula G, Mayr U, Devue C, Gallagher J, Xiao Q, Boulanger CM, Westwood N, Urbieh C, Willeit J, Steiner M, Breuss J, Xu Q, Kiechl S, Mayr M. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 1 14: 723-732, 2009.
22. Raval Z, Losordo DW. Cell therapy of peripheral arterial disease: from experimental findings to clinical trials. Circ Res 112: 1288-1302, 2013.
23. Rustenieyer P, Wittkowski W, Jurk K, Koller A. Optimized flow cytometric analysis of endothelial progenitor cells in perpheral blood. J Immunoassay Immunochem 27: 77-88, 2006.
24. Tomas E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y, Kuderinan NB. Hyperglycemia and insulin resistance: possible mechanisms. Ann NY Acad Sci 967: 43-51, 2002.
25. Tong M, Longato L, Ramirez T, Zabala V, Wands JR, de la Monte SM. Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin. Int J Exp Pathol 95: 49-63, 2014.
26. Trombetta A, Togliatto G, Rosso A, Dentelli P, Olgasi C, Cotogni P, Brizzi MF. Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the STAT5/PPARγ transcriptional complex. Diabetes 62: 1245- 1257, 2013.
27. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmelcr S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103: 2885-2890, 2001.
28. Wojakowski W, Kucia M, Liu R, Zuba-Surma E, Jadczyk T, Bachowski R, Nabialek E, Kazmierski M, Ratajczak MZ, Tendera M. Circulating very small embryonic-like stem cells in cardiovascular disease. J Cardiovasc Transl Res 4: 138-144, 2011.
29. Xiao-Yun X, Zhuo-Xiong C, Min-Xiang L, Xingxuan H, Schuchman EH, Feng L, Han-Song X, An-Hua L. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells. Med Sci Monitor 15: BR254-BR261, 2009.
30. Zhou Q, Zhang L, Fu XQ, Chen GQ. Quantitation of yeast ceramides using high-performance liquid chromatography-evaporative light-scattering detection. J Chromatogr B Analyt TechnoI Biomed Life Sci 780: 161- 169, 2002.